Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae
ABSTRACT: Objectives: Clinical experience with ceftazidime-avibactam (CAZ-AVI) for the treatment of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections is not well evaluated. The aim of this study was to assess its efficacy in a single-centre cohort of patients infected with CR-KP. Method...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2021-09-01
|
| Schriftenreihe: | Journal of Global Antimicrobial Resistance |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2213716521001223 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|